MedTrace Logo

Prophylactic Substrate Ablation in Post-myocardial Patients Undergoing Defibrillator Implantation.

NCT02780947 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-05-24

No results posted yet for this study

Summary

Prophylactic substrate ablation in post-MI patients undergoing defibrillator implantation reduces appropriate defibrillator therapies.

Conditions

Interventions

PROCEDURE

Ventricular tachycardia substrate ablation

Study protocol 1. Baseline programmed ventricular stimulation performed from the LV 2. High density endocardial LV mapping using CARTO® 3 System 3. Randomized substrate ablation in half patients. Ablation end-point is considered the elimination of all endocardial late and early potentials (LPs and EPs) 4. Final programmed ventricular stimulation performed from the LV Programmed ventricular stimulation with up to 4 extrastimuli from LV is performed and repeated at the end of the procedure in patients undergoing substrate ablation.

Sponsors & Collaborators

  • Biosense Webster, Inc.

    collaborator INDUSTRY

  • Spyridon Deftereos

    lead OTHER

Principal Investigators

  • George Giannopoulos, MD · Attikon Hospital, University of Athens

  • Charis Kossyvakis, MD · Athens General Hospital "G. Gennimatas"

  • Spyros Deftereos, MD · Attikon Hospital, University of Athens

  • Dimitris Tsiachris, MD · Athens Heart Center, Athens Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2020-06-30
Completion
2020-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02780947 on ClinicalTrials.gov